ArticleEClinicalMedicine2023

Bosentan for high-risk outpatients with COVID-19 infection: a randomized, double blind, placebo-controlled trial.

Shaahin Shahbazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.